Quest Diagnostics (DGX) Tops Q2 EPS by 30c; updates guidance
Tweet
Share
E-mail
Get Alerts DGX Hot Sheet
Price: $244.39 +1.28%
Financial Fact:
Net income attributable to Quest Diagnostics: 192M
Today's EPS Names:
ENSV, MOND, SHWZ, More
Financial Fact:
Net income attributable to Quest Diagnostics: 192M
Today's EPS Names:
ENSV, MOND, SHWZ, More
Join SI Premium – FREE
Quest Diagnostics (NYSE: DGX) reported Q2 EPS of $3.12, $0.30 better than the analyst estimate of $2.82. Revenue for the quarter came in at $3.04 billion versus the consensus estimate of $2.97 billion.
GUIDANCE:
Quest Diagnostics sees FY2026 EPS of $11.05-$11.25, versus the consensus of $10.77. Quest Diagnostics sees FY2026 revenue of $11.95-12.05 billion, versus the consensus of $11.853 billion.
For earnings history and earnings-related data on Quest Diagnostics (DGX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- JPMorgan Upgrades East Japan Railway Co (9020:JP) to Overweight
- CICC Starts Cummins (CMI) at Outperform
- DoorDash Inc. (DASH) Reiterated at Market Outperform by Citizens
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
